| Patent | Date |
|---|
Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using Same
App 20220296589 - GARLAND; Anthony Chris ; et al. | 2022-09-22 |
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods of making and using same
Grant 11,426,403 - Garland , et al. August 30, 2 | 2022-08-30 |
Transdermal Tropane Compositions And Methods For Using The Same
App 20220218689 - HAYNES; Russell ; et al. | 2022-07-14 |
A Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl Steroid
App 20220169674 - Watson; Paul Steven ; et al. | 2022-06-02 |
Pharmaceutical formulations
Grant 11,266,649 - Xu , et al. March 8, 2 | 2022-03-08 |
Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid
Grant 11,236,121 - Watson , et al. February 1, 2 | 2022-02-01 |
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
Grant 11,185,544 - Garland , et al. November 30, 2 | 2021-11-30 |
Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
Grant 10,987,342 - Pongpeerapat , et al. April 27, 2 | 2021-04-27 |
Pharmaceutical Formulations
App 20210060020 - Xu; Jingrong ; et al. | 2021-03-04 |
Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
Grant 10,874,642 - Pongpeerapat , et al. December 29, 2 | 2020-12-29 |
Dexmedetomidine transdermal delivery devices and methods for using the same
Grant 10,772,871 - Pongpeerapat , et al. Sept | 2020-09-15 |
Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same
Grant 10,617,655 - Pongpeerapat , et al. | 2020-04-14 |
Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Trans
App 20200093800 - Pongpeerapat; Adchara ; et al. | 2020-03-26 |
Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance
Grant 10,434,150 - Berner , et al. O | 2019-10-08 |
Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using
App 20190209557 - Garland; Anthony Chris ; et al. | 2019-07-11 |
Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, and Methods of Making and Using Same
App 20190209556 - Garland; Anthony Chris ; et al. | 2019-07-11 |
Naloxone Transdermal Delivery Devices and Methods for Using the Same
App 20190175519 - Haynes; Russell ; et al. | 2019-06-13 |
A Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl Steroid
App 20190177359 - Watson; Paul Steven ; et al. | 2019-06-13 |
Topical Sphingosine-1-Phosphate Receptor Agonist Formulations and Methods of Using the Same
App 20190151259 - Pongpeerapat; Adchara ; et al. | 2019-05-23 |
Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same
Grant 10,188,616 - Pongpeerapat , et al. Ja | 2019-01-29 |
Topical Sphingosine-1-Phosphate Receptor Agonist Formulations and Methods of Using the Same
App 20180289640 - Pongpeerapat; Adchara ; et al. | 2018-10-11 |
Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same
Grant 10,022,340 - Pongpeerapat , et al. July 17, 2 | 2018-07-17 |
Compositions For Ileo-jejunal Drug Delivery
App 20180193274 - NUNN; Philip A. ; et al. | 2018-07-12 |
Formulation for oral administration of proteins
Grant 9,993,531 - Siegel , et al. June 12, 2 | 2018-06-12 |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
Grant 9,980,903 - Berner , et al. May 29, 2 | 2018-05-29 |
Site Specific Dosing Of A Btk Inhibitor
App 20180015088 - NUNN; Philip ; et al. | 2018-01-18 |
Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
Grant 9,801,816 - Berner , et al. October 31, 2 | 2017-10-31 |
Shell-and-core Dosage Form Approaching Zero-order Drug Release
App 20170172930 - Berner; Bret ; et al. | 2017-06-22 |
Shell-and-core dosage form approaching zero-order drug release
Grant 9,597,338 - Berner , et al. March 21, 2 | 2017-03-21 |
Methods Of Treatment Using A Gastric Retained Gabapentin Dosage Form
App 20160263044 - Berner; Bret ; et al. | 2016-09-15 |
Formulation for Oral Administration of Proteins
App 20160235825 - Siegel; Matthew J. ; et al. | 2016-08-18 |
Gastric Retentive Dosage Forms For Extended Release Of Acamprosate Into The Upper Gastrointestinal Tract
App 20160184224 - Berner; Bret ; et al. | 2016-06-30 |
Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
Grant 9,301,934 - Berner , et al. April 5, 2 | 2016-04-05 |
Formulations Containing Reversible Covalent Compounds
App 20160045503 - Goldstein; David Michael ; et al. | 2016-02-18 |
Pulsatile Gastric Retentive Dosage Forms
App 20160038411 - Cowles; Verne Earle ; et al. | 2016-02-11 |
Methods and Pharmaceutical Compositions for Treating Celiac Disease and Gluten Intolerance
App 20150352195 - Berner; Bret ; et al. | 2015-12-10 |
Formulation for Oral Administration of Proteins
App 20150184146 - Siegel; Matthew J. ; et al. | 2015-07-02 |
Shell-and-core Dosage Form Approaching Zero-order Drug Release
App 20150182541 - Berner; Bret ; et al. | 2015-07-02 |
Gastric Retentive Dosage Forms For Extended Release Of Acamprosate Into The Upper Gastrointestinal Tract
App 20150164832 - Berner; Bret ; et al. | 2015-06-18 |
Methods Of Treatment Using A Gastric Retained Gabapentin Dosage Form
App 20150157558 - Berner; Bret ; et al. | 2015-06-11 |
Dosage forms that facilitate rapid activation of barley protease zymogen
Grant 9,017,667 - Berner April 28, 2 | 2015-04-28 |
Topical Sphingosine-1-Phosphate Receptor Agonist Formulations and Methods of Using the Same
App 20150104497 - Pongpeerapat; Adchara ; et al. | 2015-04-16 |
Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions
App 20150098997 - Pongpeerapat; Adchara ; et al. | 2015-04-09 |
Methods and Compositions for Treating Withdrawal Syndromes Using Non-Sedative Dexmedetomidine Transdermal Compositions
App 20150098983 - Pongpeerapat; Adchara ; et al. | 2015-04-09 |
Methods and Compositions for Transdermal Delivery of a Non-Sedative Amount of Dexmedetomidine
App 20150098981 - Pongpeerapat; Adchara ; et al. | 2015-04-09 |
Dexmedetomidine Transdermal Delivery Devices and Methods for Using the Same
App 20150098980 - Pongpeerapat; Adchara ; et al. | 2015-04-09 |
Methods and Compositions for Managing Pain Comprising Dexmedetomidine Transdermal Compositions
App 20150098982 - Pongpeerapat; Adchara ; et al. | 2015-04-09 |
Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
Grant 9,000,046 - Berner , et al. April 7, 2 | 2015-04-07 |
Formulation for oral administration of proteins
Grant 8,980,254 - Siegel , et al. March 17, 2 | 2015-03-17 |
Shell-and-core dosage form approaching zero-order drug release
Grant 8,945,619 - Berner , et al. February 3, 2 | 2015-02-03 |
Methods of treatment using a gastric retained gabapentin dosage form
Grant 8,802,157 - Berner , et al. August 12, 2 | 2014-08-12 |
Gastric Retentive Gabapentin Dosage Forms And Methods For Using Same
App 20140135395 - Berner; Bret ; et al. | 2014-05-15 |
Gastric Retained Gabapentin Dosage Form
App 20140072623 - Berner; Bret ; et al. | 2014-03-13 |
Compositions And Methods For Treating Gastrointestinal Motility Dysfunction
App 20130316002 - Berner; Bret | 2013-11-28 |
Gastric retentive gabapentin dosage forms and methods for using same
Grant 8,592,481 - Berner , et al. November 26, 2 | 2013-11-26 |
Methods Of Treatment Using A Gastric Retained Gabapentin Dosage Form
App 20130302417 - Berner; Bret ; et al. | 2013-11-14 |
Gastric retained gabapentin dosage form
Grant 8,580,303 - Berner , et al. November 12, 2 | 2013-11-12 |
Methods of treatment using a gastric retained gabapentin dosage
Grant 8,529,955 - Berner , et al. September 10, 2 | 2013-09-10 |
Gastric Retained Gabapentin Dosage Form
App 20130224289 - Berner; Bret ; et al. | 2013-08-29 |
Methods of treatment using a gastric retained gabapentin dosage
Grant 8,475,813 - Berner , et al. July 2, 2 | 2013-07-02 |
Shell-and-core Dosage Form Approaching Zero-order Drug Release
App 20130164377 - Berner; Bret ; et al. | 2013-06-27 |
Methods For Treating Vasomotor Symptoms Using Gaba Analogs In A Gastric Retentive Dosage Form
App 20130158121 - Berner; Bret ; et al. | 2013-06-20 |
Gastric Retentive Oral Dosage Form With Restricted Drug Release In The Lower Gastrointestinal Tract
App 20130149379 - Berner; Bret ; et al. | 2013-06-13 |
Methods of treatment using a gastric retained gabapentin dosage
Grant 8,440,232 - Berner , et al. May 14, 2 | 2013-05-14 |
Gastric Retentive Gabapentin Dosage Forms And Methods For Using Same
App 20130116320 - Berner; Bret ; et al. | 2013-05-09 |
Gastric retained gabapentin dosage form
Grant 8,409,613 - Berner , et al. April 2, 2 | 2013-04-02 |
Gastric retained gabapentin dosage form
Grant 8,333,992 - Berner , et al. December 18, 2 | 2012-12-18 |
Gastric retained gabapentin dosage form
Grant 8,333,991 - Berner , et al. December 18, 2 | 2012-12-18 |
Methods for treating vasomotor symptoms using GABA analogs in a gastric retentive dosage form
Grant 8,329,750 - Berner , et al. December 11, 2 | 2012-12-11 |
Shell and core dosage form approaching zero-order drug release
Grant 8,329,215 - Berner , et al. December 11, 2 | 2012-12-11 |
Gastric Retained Gabapentin Dosage Form
App 20120289601 - Berner; Bret ; et al. | 2012-11-15 |
Gastric Retained Gabapentin Dosage Form
App 20120282307 - Berner; Bret ; et al. | 2012-11-08 |
Gastric retained gabapentin dosage form
Grant 8,252,332 - Berner , et al. August 28, 2 | 2012-08-28 |
Gastric retained gabapentin dosage form
Grant 8,231,905 - Berner , et al. July 31, 2 | 2012-07-31 |
Gastric Retained Gabapentin Dosage Form
App 20120148671 - Berner; Bret ; et al. | 2012-06-14 |
Gastric retained gabapentin dosage form
Grant 8,192,756 - Berner , et al. June 5, 2 | 2012-06-05 |
Methods Of Treatment Using A Gastric Retained Gabapentin Dosage
App 20120128735 - BERNER; Bret ; et al. | 2012-05-24 |
Gastric Retentive Dosage Forms For Extended Release Of Acamprosate Into The Upper Gastrointestinal Tract
App 20120077878 - Berner; Bret ; et al. | 2012-03-29 |
Gastric Retained Gabapentin Dosage Form
App 20120064129 - Berner; Bret ; et al. | 2012-03-15 |
Methods Of Treatment Using A Gastric Retained Gabepentin Dosage
App 20120064168 - BERNER; BRET ; et al. | 2012-03-15 |
Methods of treatment using a gastric retained gabapentin dosage
Grant 8,119,166 - Berner , et al. February 21, 2 | 2012-02-21 |
Methods Of Treatment Using A Gastric Retained Gabapentin Dosage
App 20120027823 - Berner; Bret ; et al. | 2012-02-02 |
Gastric Retentive Oral Dosage Form With Restricted Drug Release In The Lower Gastrointestinal Tract
App 20110301129 - BERNER; BRET ; et al. | 2011-12-08 |
Shell-and-core dosage form approaching zero-order drug release
Grant 8,043,630 - Berner , et al. October 25, 2 | 2011-10-25 |
Gastric Retained Gabapentin Dosage Form
App 20110256223 - BERNER; BRET ; et al. | 2011-10-20 |
Shell And Core Dosage Form Approaching Zero-order Drug Release
App 20110236485 - BERNER; BRET ; et al. | 2011-09-29 |
Dosage Forms That Facilitate Rapid Activation of Zymogen
App 20110236369 - Berner; Bret | 2011-09-29 |
Methods Of Treating Non-nociceptive Pain States With Gastric Retentive Gabapentin
App 20110218246 - Berner; Bret ; et al. | 2011-09-08 |
Formulation for Oral Administration of Proteins
App 20110171201 - Siegel; Matthew John ; et al. | 2011-07-14 |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
Grant 7,976,870 - Berner , et al. July 12, 2 | 2011-07-12 |
Monitoring of physiological analytes
Grant 7,873,399 - Berner , et al. January 18, 2 | 2011-01-18 |
Shell-and-Core Dosage Form Approaching Zero-Order Drug Release
App 20100272808 - Berner; Bret ; et al. | 2010-10-28 |
Gastric Retained Gabapentin Dosage Form
App 20100247610 - Berner; Bret ; et al. | 2010-09-30 |
Shell-and-core dosage form approaching zero-order drug release
Grant 7,736,667 - Berner , et al. June 15, 2 | 2010-06-15 |
Gastric retained gabapentin dosage form
Grant 7,731,989 - Berner , et al. June 8, 2 | 2010-06-08 |
Methods Of Treatment Using A Gastric Retained Gabapentin Dosage
App 20100034895 - Berner; Bret ; et al. | 2010-02-11 |
Methods of treatment using a gastric retained gabapentin dosage
Grant 7,612,112 - Berner , et al. November 3, 2 | 2009-11-03 |
Methods For Treating Vasomotor Symptoms Using Gaba Analogs In A Gastric Retentive Dosage Form
App 20090209645 - Berner; Bret ; et al. | 2009-08-20 |
Gastric Retentive Gabapentin Dosage Forms And Methods For Using Same
App 20090176882 - Berner; Bret ; et al. | 2009-07-09 |
Pulsatile gastric retentive dosage forms
App 20090028941 - Cowles; Verne Earle ; et al. | 2009-01-29 |
Gastric Retained Gabapentin Dosage Form
App 20090017121 - Berner; Bret ; et al. | 2009-01-15 |
Methods of treatment using a gastric retained gabapentin dosage
Grant 7,438,927 - Berner , et al. October 21, 2 | 2008-10-21 |
Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
Grant 7,405,238 - Markey , et al. July 29, 2 | 2008-07-29 |
Signal processing for measurement of physiological analytes
Grant 7,295,867 - Berner , et al. November 13, 2 | 2007-11-13 |
Gastric retentive gabapentin dosage forms and methods for using same
App 20070184104 - Berner; Bret ; et al. | 2007-08-09 |
Monitoring of physiological analytes
App 20070142721 - Berner; Bret ; et al. | 2007-06-21 |
Signal processing for measurement of physiological analytes
App 20070038053 - Berner; Bret ; et al. | 2007-02-15 |
Monitoring a physiological analytes
Grant 7,174,199 - Berner , et al. February 6, 2 | 2007-02-06 |
Methods of treating non-nociceptive pain states with gastric retentive gabapentin
App 20060159743 - Berner; Bret ; et al. | 2006-07-20 |
Biosensor and methods of use thereof
Grant 6,999,810 - Berner , et al. February 14, 2 | 2006-02-14 |
Monitoring of physiological analytes
App 20050215872 - Berner, Bret ; et al. | 2005-09-29 |
Methods of treatment using a gastric retained gabapentin dosage
App 20050064036 - Berner, Bret ; et al. | 2005-03-24 |
Biosensor and methods of use thereof
App 20050027179 - Berner, Bret ; et al. | 2005-02-03 |
Monitoring of physiological analytes
Grant 6,850,790 - Berner , et al. February 1, 2 | 2005-02-01 |
Biosensor and methods of use thereof
Grant 6,816,742 - Kim , et al. November 9, 2 | 2004-11-09 |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
App 20040185105 - Berner, Bret ; et al. | 2004-09-23 |
Biosensor and methods of use thereof
App 20040167383 - Kim, Lynn ; et al. | 2004-08-26 |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
App 20040156899 - Louie-Helm, Jenny ; et al. | 2004-08-12 |
Optimal polymer mixtures for gastric retentive tablets
Grant 6,723,340 - Gusler , et al. April 20, 2 | 2004-04-20 |
Hydrogel formulations for use in electroosmotic extraction and detection of glucose
App 20040062759 - Abraham, William ; et al. | 2004-04-01 |
Monitoring of physiological analytes
App 20030195403 - Berner, Bret ; et al. | 2003-10-16 |
Formulation of an erodible, gastric retentive oral diuretic
App 20030152622 - Louie-Helm, Jenny ; et al. | 2003-08-14 |
Signal processing for measurement of physiological analytes
App 20030153820 - Berner, Bret ; et al. | 2003-08-14 |
Signal processing for measurement of physiological analytes
App 20030153821 - Berner, Bret ; et al. | 2003-08-14 |
Device for signal processing for measurement of physiological analytes
Grant 6,595,919 - Berner , et al. July 22, 2 | 2003-07-22 |
Biosensor, iontophoretic sampling system, and methods of use thereof
App 20030135100 - Kim, Lynn ; et al. | 2003-07-17 |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
App 20030133985 - Louie-Helm, Jenny ; et al. | 2003-07-17 |
Device for monitoring of physiological analytes
Grant 6,594,514 - Berner , et al. July 15, 2 | 2003-07-15 |
Biosensor, iontophoretic sampling system, and methods of use thereof
Grant 6,587,705 - Kim , et al. July 1, 2 | 2003-07-01 |
Shell-and-core dosage form approaching zero-order drug release
App 20030104062 - Berner, Bret ; et al. | 2003-06-05 |
Optimal Polymer Mixtures For Gastric Retentive Tablets
App 20030104053 - Gusler, Gloria ; et al. | 2003-06-05 |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
App 20030104052 - Berner, Bret ; et al. | 2003-06-05 |
Methods of treatment using a gastric retained gabapentin dosage
App 20030100611 - Berner, Bret ; et al. | 2003-05-29 |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
App 20030091630 - Louie-Helm, Jenny ; et al. | 2003-05-15 |
Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
App 20030044466 - Markey, Micheline ; et al. | 2003-03-06 |
Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
App 20030031711 - Fara, John W. ; et al. | 2003-02-13 |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
Grant 6,488,962 - Berner , et al. December 3, 2 | 2002-12-03 |
Monitoring of physiological analytes
App 20020091312 - Berner, Bret ; et al. | 2002-07-11 |
Device for monitoring of physiological analytes
Grant 6,356,776 - Berner , et al. March 12, 2 | 2002-03-12 |
Signal processing for measurement of physiological analytes
App 20010016682 - Berner, Bret ; et al. | 2001-08-23 |
Signal processing for measurement of physiological analysis
Grant 6,233,471 - Berner , et al. May 15, 2 | 2001-05-15 |
Monitoring of physiological analytes
Grant 6,144,869 - Berner , et al. November 7, 2 | 2000-11-07 |
Temporally controlled drug delivery systems
Grant 6,068,853 - Giannos , et al. May 30, 2 | 2000-05-30 |
Mixed solvent mutually enhanced transdermal therapeutic system
Grant 5,925,372 - Berner , et al. July 20, 1 | 1999-07-20 |
Article useful for administration of pharmacologically-active substances transdermally, orally or by means of implant
Grant 5,468,501 - Kydonieus , et al. * November 21, 1 | 1995-11-21 |
Copolymer of (meth)acryloxy-alkyl-siloxysilane and alkyl(meth)acrylates and the use thereof as pressure sensitive adhesives
Grant 5,288,827 - Li , et al. February 22, 1 | 1994-02-22 |
Article useful for administration of pharmacologically-active substances transdermally, orally, or by means of implant
Grant RE34,089 - Kydonieus , et al. October 6, 1 | 1992-10-06 |
Transdermal administration of zwitterionic drugs
Grant 5,073,539 - Mazzenga , et al. December 17, 1 | 1991-12-17 |
Mixed solvent mutually enhanced transdermal therapeutic system
Grant 5,064,654 - Berner , et al. November 12, 1 | 1991-11-12 |
Article useful for administration of pharmacologically-active substances transdermally, orally, or by means of implant
Grant 4,767,808 - Kydonieus , et al. August 30, 1 | 1988-08-30 |
Device for controlled release drug delivery
Grant 4,764,382 - Kydonieus , et al. August 16, 1 | 1988-08-16 |
Article useful for administration of pharmacologically-active substances transdermally, orally, or by means of implant
Grant 4,758,434 - Kydonieus , et al. July 19, 1 | 1988-07-19 |
| 